| Breakdown | TTM | Mar 2026 | Mar 2025 | Mar 2024 | Mar 2023 | Mar 2022 |
|---|---|---|---|---|---|---|
Income Statement | ||||||
| Total Revenue | 199.72B | 191.77B | 205.20B | 222.85B | 235.39B | 204.20B |
| Gross Profit | 35.97B | 32.75B | 36.24B | 39.43B | 34.60B | 17.45B |
| EBITDA | 18.52B | 15.09B | 18.82B | 22.80B | 18.43B | 2.95B |
| Net Income | 11.43B | 8.05B | 11.32B | 15.19B | 12.51B | -1.11B |
Balance Sheet | ||||||
| Total Assets | 252.95B | 255.51B | 254.16B | 270.81B | 253.55B | 223.38B |
| Cash, Cash Equivalents and Short-Term Investments | 25.76B | 26.50B | 28.40B | 24.39B | 21.95B | 16.61B |
| Total Debt | 62.16B | 54.32B | 64.42B | 70.27B | 76.27B | 71.86B |
| Total Liabilities | 117.12B | 111.25B | 119.41B | 142.20B | 141.18B | 124.32B |
| Stockholders Equity | 135.38B | 143.79B | 134.30B | 128.18B | 111.96B | 98.66B |
Cash Flow | ||||||
| Free Cash Flow | 0.00 | 12.44B | 12.91B | 12.46B | 1.48B | -7.94B |
| Operating Cash Flow | 0.00 | 21.43B | 19.14B | 17.84B | 6.71B | -2.13B |
| Investing Cash Flow | 0.00 | -9.59B | -5.68B | -4.94B | -4.86B | -5.25B |
| Financing Cash Flow | 0.00 | -13.73B | -9.45B | -10.46B | 3.50B | 9.54B |
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
|---|---|---|---|---|---|---|---|
75 Outperform | ¥434.26B | 12.05 | ― | 3.26% | -6.84% | 4.65% | |
71 Outperform | ¥180.09B | 27.66 | 5.06% | 1.80% | 1.69% | 71.95% | |
69 Neutral | ¥739.64B | 7.95 | 10.78% | 4.68% | -4.64% | -21.94% | |
66 Neutral | ¥39.13B | 8.84 | ― | 6.27% | -6.54% | -28.89% | |
62 Neutral | ¥371.52B | 11.21 | 6.16% | 2.99% | 0.55% | 20.51% | |
61 Neutral | $10.43B | 7.12 | -0.05% | 2.87% | 2.86% | -36.73% | |
58 Neutral | ¥78.83B | 13.13 | ― | 3.70% | -2.40% | -8.59% |